AI assistant
Sending…
AMICUS THERAPEUTICS, INC. — Director's Dealing 2012
Feb 14, 2012
31523_dirs_2012-02-14_04218d85-6626-48a2-ab14-cdf74b0231b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2011-12-31
Reporting Person: Crowley John F (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-16 | Common Stock | G | 100000 | $0.00 | Disposed | 9867 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 100000 | Indirect |
Footnotes
F1: Mr. Crowley transferred 100,000 shares to the John F. Crowley 2011 GRAT f/b/o John F. Crowley.
More from AMICUS THERAPEUTICS, INC.
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Transaction in Own Shares
2026
Apr 27
Transaction in Own Shares
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Transaction in Own Shares
2026
Apr 27
Regulatory Filings
2026
Apr 27